MBTPS1 and Kaposi's sarcoma: Additionally, exogenous C1P and S1P were found to stimulate proliferation of these cells [84], suggesting that both bioactive sphingolipids are relevant for development of Kaposi sarcoma; targeting C1P and S1P signaling may turn out to be a useful therapeutic approach to treat the disease.